For examples, hepatic expressions of lipogenic genes and de novo lipogenesis was reduced during fasting38; however, in NAFLD patients, expressions of hepatic ACC and FAS were upregulated39 and de novo lipogenesis is generally increased14. This evidence concerns the gene FAS and metabolic dysfunction-associated steatotic liver disease.